Patton Curtis L. 4

What Happened
Curtis L. Patton, a director of Tevogen Bio Holdings, was granted 40,000 restricted shares on July 10, 2026 (transaction code A). The shares were issued at $0.00 per share (total reported acquisition value $0). This was a grant/award of restricted stock rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-10 (filed the same day)
• Transaction type/code: Grant/Award (A) of 40,000 restricted shares at $0.00 (total $0)
• Shares owned after transaction: Not specified in the filing
• Vesting/conditions (footnote F1): The award vests in three equal installments upon the earlier of each anniversary (1st, 2nd, 3rd) and the company achieving cumulative revenue milestones of $50M, $100M, and $150M respectively, provided Patton remains in service on each applicable vesting date.
• Timeliness: Filing shows the transaction and report date as 2026-07-10 (no late filing indicated)

Context
Restricted stock awards are common compensation for directors and are subject to vesting and service requirements; they do not represent an immediate sale or cash out. Because vesting here is tied to both tenure and company revenue milestones, the shares may not become freely tradable until those conditions are met.